What is the treatment for Rhabdomyolysis (muscle breakdown disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Rhabdomyolysis

Aggressive intravenous fluid resuscitation is the cornerstone of rhabdomyolysis treatment, with immediate initiation of >6L per day for severe cases (CK >15,000 IU/L) and 3-6L per day for moderate cases, targeting a urine output of 300 mL/hour to prevent acute kidney injury. 1, 2, 3

Immediate Management Algorithm

Step 1: Discontinue Offending Agents

  • Immediately stop any causative medications, particularly statins, which cause rhabdomyolysis at a rate of 1.6 per 100,000 patient-years 1
  • Discontinue dietary supplements including red yeast rice (contains lovastatin), creatine monohydrate, wormwood oil, licorice, and Hydroxycut 1
  • Avoid succinylcholine in the perioperative setting as it can exacerbate rhabdomyolysis 1

Step 2: Aggressive Fluid Resuscitation

  • Begin isotonic saline (0.9% NaCl) immediately - delayed fluid resuscitation significantly increases acute kidney injury risk 1, 2, 4
  • For severe rhabdomyolysis (CK >15,000 IU/L): administer >6L of IV fluids daily 1, 2
  • For moderate rhabdomyolysis: administer 3-6L of IV fluids daily 1, 2
  • Target urine output of 300 mL/hour to ensure adequate kidney perfusion 2, 3
  • Early vigorous fluid resuscitation (≥12L daily in some protocols) has reduced mortality from nearly 100% to <20% in crush syndrome over the past 70 years 4

Critical pitfall: Do not use diuretics as primary treatment - they may increase acute kidney injury risk unless adequate volume resuscitation has been achieved first 2. Mannitol may only benefit patients with CK >30,000 U/L and is contraindicated in oligoanuria 2.

Step 3: Monitor and Correct Electrolyte Abnormalities

  • Check potassium levels immediately and obtain ECG - hyperkalemia causes life-threatening cardiac arrhythmias 1, 2
  • Perform repeated measurements of plasma myoglobin, CK, and potassium 1, 2
  • Monitor calcium, phosphorus, and magnesium levels 1
  • Assess for metabolic acidosis with arterial blood gas 1
  • Use bladder catheterization to monitor hourly urine output 2

Step 4: Assess for Compartment Syndrome

  • Early signs: pain, tension, paresthesia, and paresis 1, 5
  • Late signs (often irreversible): pulselessness and pallor 1, 5
  • Perform early fasciotomy when compartment pressure exceeds 30 mmHg or when differential pressure (diastolic BP - compartment pressure) is <30 mmHg 1, 5

Laboratory Workup

  • Complete electrolyte panel (potassium, calcium, phosphorus, magnesium) 1
  • Creatine kinase (diagnosis requires CK >5 times upper limit of normal) 3
  • Creatinine and BUN for renal function 1
  • Urinalysis showing brown color, cloudiness, and positive for blood without RBCs indicates myoglobinuria 1
  • Liver function tests to assess hepatic involvement 1
  • Coagulation studies to evaluate for disseminated intravascular coagulation 1

Renal Replacement Therapy

  • Consider dialysis for myoglobinuric renal failure on a case-by-case basis 1, 3
  • Indications include severe oliguria despite adequate fluid resuscitation, refractory hyperkalemia, or severe metabolic acidosis 6

Post-Acute Management for Statin-Induced Cases

  • Do not rechallenge with the same statin 1
  • Consider nonstatin therapies including ezetimibe, PCSK9 inhibitors, or bempedoic acid for continued lipid management 1
  • If lipid management is essential, use hydrophilic statins (fluvastatin, pravastatin) as they have fewer metabolic interactions 1
  • Refer to neurologist specializing in neuromuscular disorders if autoimmune myopathy is suspected 5

Special Populations

Exertional Rhabdomyolysis

  • Properly calibrate training and conditioning sessions, especially during transition periods (returning after injury) 1
  • Maintain adequate hydration throughout exercise 1

Drug Interactions

  • Avoid combining statins with ciclosporin, macrolides, azole antifungals, calcium antagonists, protease inhibitors, or fibrates 7
  • Use hydrophilic statins if concurrent medications metabolized by CYP3A4 are necessary 1

Admission Criteria

  • Hospitalize patients with: immunocompromised state, severe pain requiring management, mental confusion, pulmonary infiltrates, abnormal spinal fluid findings, or organ failure 1
  • Most patients with rhabdomyolysis require admission, though select cases with mild elevation and adequate oral hydration may be discharged with close follow-up 3

Key evidence note: Bicarbonate and mannitol do not possess strong evidence for improved outcomes in rhabdomyolysis 3. The single most important intervention remains early, aggressive isotonic fluid resuscitation 4.

References

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fluid Administration in Rhabdomyolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early fluid resuscitation in patients with rhabdomyolysis.

Nature reviews. Nephrology, 2011

Guideline

Rhabdomyolysis with Rash Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rhabdomyolysis as a manifestation of a metabolic disease: a case report.

Revista Brasileira de terapia intensiva, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.